ARCHIVES

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 10, 1989

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Members Names, First Meeting Scheduled For Nov. 8-9

September 24, 1976

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment

May 23, 2014

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008